420 with CNW — Retired NFL Player Unveils Novel CBD Products Derived from Orange Peels

August 13, 2021 15:25:33

If you thought you had heard it all with regard to CBD, here is a shocker: your next dose of CBD could be extracted from orange peels. Before you think this will be in the distant future, a company started by a former NFL star has launched this orange-peel -derived CBD, and you can buy yourself a bottle online today.

Peels, as the orange-peel CBD firm is called, says that its product will be purer, more consistent, more stable and have absolutely no THC in it. Chris Hetherington, the founder of Peels, explains that these benefits will make Peels’s CBD more accessible…


NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

Denver, Colorado
303.498.7722 Office

CNW420 is part of the InvestorBrandNetwork.